stability
Ensuring Stability the Biggest Amorphous Challenge for 88.2% of Developers
July 27 by Pharma IQThe use of amorphous pharmaceutical materials is widely considered an effective way of improving favourable drug properties and the latest findings from Pharma IQ suggest that many developers consider...
3 Tips on Overcoming Poor Aqueous Solubility and Stability
February 15 by Helen WinsorWhat are the 7 Deadly Sins of Quality Assurance and Quality Control? Download our free QA QC eBook now to find out! Rene Holm, Head of Preformulation at H L...
Utilising Accelerated Degradation Studies to Better Predict Product Stability
November 26 by Pharma IQDr. Paul Matejtschuk Principal Scientist at NIBSC, joins Andrea Charles from Pharma IQ, to address the key challenges in optimal formulation development and how advances in freeze drying have imp...
Biotech Boom Drives Lyophilisation
August 05 by Andrea CharlesBiological shift A growing biotechnology pipeline is fuelling the demand for lyophilisation technologies, and drug companies are looking to partner with contract manufacturing organisations (CMOs...
The Challenges of Amorphous Solid Dispersion Production: A Hoffman La Roche Perspective
July 11 by Pharma IQDr. Dave Miller, Senior Principal Scientist at Hoffmann La Roche, shares his views on how to optimise amorphous form selection, techniques to enhance amorphous drug performance and the best strategies...
Drug Discovery and the Market Today Part 2: Critical Thoughts on Stability
June 09 by Pharmaceuticals & Biotechnology EditorWhat are the 7 Deadly Sins of Quality Assurance and Quality Control? Download our free QA QC eBook now to find out!
Getting to Grips with Stability Testing and Regulatory Compliance
April 25 by Helen WinsorWhat are the 7 Deadly Sins of Quality Assurance and Quality Control? Download our free QA QC eBook now to find out! Find out more about the challenges in pre-and post-release stability te...
European Regulatory Guidelines Controlled or Ambient Temperatures, Stability Data and Compliance
April 25 by Pharmaceuticals & Biotechnology EditorThere is more regulatory interest in ambient products and growing opportunities for solution providers to enter this market. In this presentation Ian Holloway, Manager, Defective Medicines Report Ce...